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REPLY
In differentiating the etiology of cardiomyopathies, the greatest
danger is mislabeling an ischemic (with subsequent revasculariza-
tion as a treatment option) as a nonischemic cardiomyopathy
(relegated to medical therapy or heart transplantation). Some
physicians even suggest that all patients with heart failure undergo
coronary angiography to exclude ischemia as an etiology. Although
routine angiography should not be implemented due to expense
and risk, there is a need for a highly sensitive test to discriminate
between these two conditions. The development of electron beam
computed tomography (EBCT) to detect coronary atherosclerosis
now provides clinicians with a noninvasive means to rule out
ischemic cardiomyopathy with 99% sensitivity (1).
With regard to evaluating coronary calcifications by other
means, chest radiography, fluoroscopy, conventional and spiral
computed tomography (CT) have each been reported (2). How-
ever, the decreased temporal and spatial resolution, slow acquisi-
tion time and inability to gate to the electrocardiogram (ECG)
limit the sensitivity of these modalities. There is evidence dating
back over 40 years that the presence of coronary calcification, as
detected by chest x-ray film or fluoroscopy, can identify patients
with advanced coronary artery disease. The sensitivity of fluoros-
copy in evaluating significant coronary artery disease ranged from
40% to 79% in seven large studies (3). Shemesh et al. (4) reported
coronary calcium imaging by double-helical CT, with accelerated
scan times, as having a sensitivity rate of 91% when compared with
angiographically significant coronary obstructive disease. However,
other preliminary data have shown that even at these accelerated
scan times, calcific deposits are blurred owing to cardiac motion,
and small calcifications may not be seen (5). The lack of ECG
gating will further limit the usefulness of these modalities. Because
sensitivity for obstructive disease is so important so as to not
misdiagnose an ischemic cardiomyopathy as nonischemic, tests
with higher sensitivities should be used when available.
Electron beam computed tomography, with its ability to acquire
images in 100 ms and gate to the ECG (to minimize coronary
motion), provides clinicians with a safe and noninvasive means to
detect and measure coronary calcium. The sensitivity of EBCT for
obstructive coronary artery disease is consistently above 95% and is
99% for multivessel disease in a large multicenter study (6). In the
study reported in JACC, (1), EBCT was demonstrated to exclude
ischemic cardiomyopathy noninvasively with a 98% negative pre-
dictive value.
Thus with regard to Shemesh, EBCT is not the only means to
evaluate coronary calcification. However, it does provide clinicians
with the most sensitive noninvasive means to discriminate between
ischemic and nonischemic cardiomyopathy.
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